In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore

In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore

Journal of Antibiotics

Saved in:

Bibliographic Details
Main Authors:	Lim, T.-P., Tan, T.-Y., Lee, W., Sasikala, S., Tan, T.-T., Hsu, L.-Y.Hsu, L.-Y., Kwa, A.L.
Other Authors:	MEDICINE
Format:	Article
Published:	2015
Subjects:	Acinetobacter species Carbapenem resistance Combination therapy
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/120852
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Evaluation of the Synergistic Antibacterial Effects of Rifampicin-based Combination Therapies for the Management of Infections due to Carbapenem-Resistant Acinetobacter baumannii
by: Nwabor, Lois Chinwe
Published: (2023)

Detection of carbapenemase genes in acinetobacter baumannii
by: Napawan Punakabutra
Published: (2012)

In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against Carbapenem-resistant Acinetobacter baumannii in Singapore
by: Lim T.-P., et al.
Published: (2019)

Importance of control groups when delineating antibiotic use as a risk factor for carbapenem resistance, extreme-drug resistance, and pan-drug resistance in Acinetobacter baumannii and Pseudomonas aeruginosa: A systematic review and meta-analysis
by: Lim, C.L.L., et al.
Published: (2021)

Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant enterobacteriaceae and carbapenemase-producing enterobacteriaceae
by: Marimuthu, Kalisvar, et al.
Published: (2020)

Multiple Antibiotics in Combination Against Extreme Drug Resistant Acinetobacter Baumannii in an In-Vitro Pharmacokinetic/Pharmacodynamic Model
by: LIM TZE PENG
Published: (2014)

In vitro antimicrobial activities of Meropenem, Colistin, and Sulbactum in double and triple combinations against multidrug-resistant Acinetobacter Baumannii
by: Suparak Amornnopparattanakul
Published: (2012)

In vitro antibacterial activity of imipenem in combination with amikacin or with ciprofloxacin against imipenem resistant-Acinetobacter baumannii
by: Saranjit Duangseesai
Published: (2008)

In vitro activity of biapenem and comparators against multidrug-resistant and carbapenem-resistant Acinetobacter baumannii isolated from tertiary care hospitals in Thailand
by: Jantana Houngsaitong, et al.
Published: (2020)

The role of hospital environment in transmissions of multidrug-resistant gram-negative organisms
by: Chia, P.Y., et al.
Published: (2021)

Treatment and Outcomes of Infections Caused by Diverse Carbapenemase-Producing Carbapenem-Resistant Enterobacterales
by: Lim, F.K., et al.
Published: (2021)

Hydrogen Sulfide Sensitizes Acinetobacter baumannii to Killing by Antibiotics
by: Ng, S.Y., et al.
Published: (2021)

Integrated pharmacokinetic–pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections
by: Lim, T.-P., et al.
Published: (2021)

Carbapenems and subsequent multiresistant bloodstream infection: does treatment duration matter?
by: Donaldson, A.D., et al.
Published: (2014)

Nosocomiaacinetobacter calcoaceticus-acinetobacter baumannii complex infection : Molecular epidemiology, resistance to carbapenems, spatio-temporal pattern and clinical outcomes
by: Sarunyou Chusri
Published: (2015)

Molecular characterization of Acinetobacter baumannii integrated with genomic resistance Island
by: Thapa, Badri, 1975-
Published: (2023)

Synergistic Effects of Meropenem in Combination with Aminoglycosides against Carbapenem-Resistant Escherichia coli Harboring Extended-Spectrum Beta-Lactamase and Carbapenemase Genes
by: Pawarisa Terbtothakun
Published: (2023)

Predictors and outcomes of healthcare-associated infections caused by carbapenem-nonsusceptible enterobacterales: a parallel matched case-control study
by: Hoo, Grace S. R., et al.
Published: (2023)

Sustaining antimicrobial stewardship in a high-antibiotic resistance setting
by: Ng, Tat Ming, et al.
Published: (2023)

Discovery of Broad-Spectrum Repurposed Drug Combinations Against Carbapenem-Resistant <i>Enterobacteriaceae</i> (CRE) Through Artificial Intelligence (AI)-Driven Platform
by: Li, Ming, et al.
Published: (2024)

Using an adenosine triphosphate bioluminescent assay to determine effective antibiotic combinations against carbapenem-resistant gram negative bacteria within 24 hours
by: Cai Y., et al.
Published: (2019)

INVESTIGATING ACINETOBACTER GENUS FROM COMMUNITY-AND HOSPITAL-ACQUIRED INFECTIONS
by: BERNICE TAN SIU YAN
Published: (2023)

Identification of acinetobacter species isolated from clinical specimen by photobiotin labelling DNA-DNA hybridization
by: Chutima Sereekul
Published: (2007)

High burden of antimicrobial drug resistance in Asia
by: Lai, C.-C., et al.
Published: (2016)

HEXIM1 peptide exhibits antimicrobial activity against antibiotic resistant bacteria through guidance of cell penetrating peptide
by: Ho, P.L., et al.
Published: (2021)

Anti-Acinetobacter baumannii Activity of Volatile Oil Extracted from Medicinal Plants
by: Piyaorn Chornchoem, et al.
Published: (2018)

Comparative genomics of two ST 195 carbapenem-resistant Acinetobacter baumannii with different susceptibility to polymyxin revealed underlying resistance mechanism
by: Lean, S.-S, et al.
Published: (2020)

HEALTHCARE-ASSOCIATED INFECTIONS IN SINGAPORE WITH A FOCUS ON INFECTIONS CAUSED BY CARBAPENEM-RESISTANT GRAM-NEGATIVE BACTERIA
by: CAI YIYING
Published: (2020)

Aeromonas dhakensis: clinical isolates with high carbapenem resistance
by: Puah, Suat Moi, et al.
Published: (2023)

Environmental colonization and onward clonal transmission of carbapenem-resistant Acinetobacter baumannii (CRAB) in a medical intensive care unit: The case for environmental hygiene
by: Ng, D.H.L, et al.
Published: (2020)

Extensively drug-resistant Acinetobacter baumannii in a Thai hospital: A molecular epidemiologic analysis and identification of bactericidal Polymyxin B-based combinations
by: Teo, J, et al.
Published: (2020)

Reactive oxygen species (ROS) and sensitization to TRAIL-induced apoptosis, in Bayesian network modelling of HeLa cell response to LY303511
by: Tucker-Kellogg, L., et al.
Published: (2014)

Prevalence and genotypic relatedness of carbapenem resistance among multidrug-resistant P. aeruginosa in tertiary hospitals across Thailand
by: Piyatip Khuntayaporn, et al.
Published: (2017)

Identification of carbapenemase genes in Acinetobacter baumannii clinical isotates from Songklanagarind hospital
by: Payom Wongpoowarak, et al.
Published: (2018)

Một số đặc tính của các chủng Acinetobacter baumannii gây nhiễm khuẩn bệnh viện mang gen NDM-1 kháng Carbapenem
by: Phạm, Duy Thái
Published: (2016)

Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore
by: Koh, T.H., et al.
Published: (2014)

Chemical basis of combination therapy to combat antibiotic resistance
by: Si, Zhangyong, et al.
Published: (2023)

In vitro activity of doripenem and other carbapenems against contemporary Gram-negative pathogens isolated from hospitalised patients in the Asia-Pacific region: Results of the COMPACT Asia-Pacific Study
by: Christiansen, K.J., et al.
Published: (2016)

Population Pharmacokinetics/Pharmacodynamics and Clinical Outcomes of Carbapenems in Critically Ill Patients
by: Apinya Boonpeng
Published: (2022)

Complete genome sequence of Acinetobacter schindleri SGAir0122 isolated from Singapore air
by: Kee, Carmon, et al.
Published: (2019)